title: Tumor cell survival dependence on helical tomotherapy, continuous arc and segmented dose delivery.
abstract: The temporal pattern of radiation delivery has been shown to influence the tumor cell survival fractions for the same radiation dose. To study the effect more specifically for state of the art rotational radiation delivery modalities, 2 Gy of radiation dose was delivered to H460 lung carcinoma, PC3 prostate cancer cells and MCF-7 breast tumor cells by helical tomotherapy (HT), seven-field LINAC (7F), and continuous dose delivery (CDD) over 2 min that simulates volumetric rotational arc therapy. Cell survival was measured by the clonogenic assay. The number of viable H460 cell colonies was 23.2 +/- 14.4% and 27.7 +/- 15.6% lower when irradiated by CDD compared with HT and 7F, respectively, and the corresponding values were 36.8 +/- 18.9% and 35.3 +/- 18.9% lower for MCF7 cells (p < 0.01). The survival of PC3 was also lower when irradiated by CDD than by HT or 7F but the difference was not as significant (p = 0.06 and 0.04, respectively). The higher survival fraction from HT delivery was unexpected because 90% of the 2 Gy was delivered in less than 1 min at a significantly higher dose rate than the other two delivery techniques. The results suggest that continuous dose delivery at a constant dose rate results in superior in vitro tumor cell killing compared with prolonged, segmented or variable dose rate delivery.
authors.affiliation: Department of Radiation Oncology, University of Virginia, VA, USA.
authors.forename: Wensha
authors.initials: W
authors.lastname: Yang
authors.forename: Li
authors.initials: L
authors.lastname: Wang
authors.forename: James
authors.initials: J
authors.lastname: Larner
authors.forename: Paul
authors.initials: P
authors.lastname: Read
authors.forename: Stan
authors.initials: S
authors.lastname: Benedict
authors.forename: Ke
authors.initials: K
authors.lastname: Sheng
mesh_terms: D045744:Cell Line, Tumor; D002470:Cell Survival / Q000528:radiation effects; D004307:Dose-Response Relationship, Radiation; D004867:Equipment Design; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D010315:Particle Accelerators; D011829:Radiation Dosage; D011874:Radiometry / Q000379:methods*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods; D013997:Time Factors; D036542:Tomography, Spiral Computed / Q000379:methods*